There are 3161 resources available
1105P - Predicting the outcomes of advanced cutaneous melanoma cases following discontinuation of immune checkpoint inhibition
Presenter: Ka-won Noh
Session: Poster session 04
1106P - NivoLag-when: International real-world study of combination immunotherapy sequences in melanoma
Presenter: Mora Guardamagna
Session: Poster session 04
1107P - Characteristics and quality of life of nine-year survivors from 312 patients with metastatic melanoma treated with pembrolizumab
Presenter: Jessica Hassel
Session: Poster session 04
1108P - Impact of quantitative imaging of all disease on the prognostic value of <sup>18</sup>F-FDG PET/CT in patients treated with immunotherapy for metastatic melanoma
Presenter: Robert Jeraj
Session: Poster session 04
1109P - Association of clinical features with long-term survival in patients with melanoma who responded to distinct checkpoint inhibitors
Presenter: Eva Ellebaek
Session: Poster session 04
1110P - Follow-up brain imaging in patients with melanoma brain metastasis and immune checkpoint inhibitors
Presenter: Imren Ozdamar
Session: Poster session 04
1111P - Genomic and transcriptomic analysis of Japanese melanoma reveals candidate biomarkers for immune checkpoint inhibitor responders
Presenter: Toshihiro Kimura
Session: Poster session 04
1112P - Immunotherapy after progression to double immunotherapy: Pembrolizumab and Lenvatinib versus conventional chemotherapy for patients with metastatic melanoma after failure of PD-1/CTLA-4 inhibition
Presenter: Dimitrios Ziogas
Session: Poster session 04
1113P - A machine learning model based on computed tomography radiomics to predict prognosis in subjects with stage IV melanoma
Presenter: Maria Teresa Maccallini
Session: Poster session 04
1114P - Deciphering unresectable in-transit metastasis in melanoma: Multi-modal and longitudinal insights
Presenter: Giuseppe Tarantino
Session: Poster session 04